Tokyo Tape
Sign in
← Euglena

Quarterly report · Q1

2931.TEDINET S100QQ85
Period2023-01-01 → 2023-03-31
Filed2023-05-12
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 32
MetricValuePeriodScopeSource row
Revenue¥10.8bn2023-01-01 → 2023-03-31Cons.Net sales
Revenue¥44.4bn2022-01-01 → 2022-12-31Cons.Net sales (5-year summary)
Revenue¥10.8bn2022-01-01 → 2022-03-31Cons.Net sales
Operating income−¥176m2023-01-01 → 2023-03-31Cons.Operating income
Operating income−¥727m2022-01-01 → 2022-03-31Cons.Operating income
Ordinary income−¥111m2023-01-01 → 2023-03-31Cons.Ordinary income
Ordinary income−¥2.5bn2022-01-01 → 2022-12-31Cons.Ordinary income loss (5-year summary)
Ordinary income¥81m2022-01-01 → 2022-03-31Cons.Ordinary income
Profit before tax−¥81m2023-01-01 → 2023-03-31Cons.Income before income taxes
Profit before tax¥83m2022-01-01 → 2022-03-31Cons.Income before income taxes
Net income (owners)−¥167m2023-01-01 → 2023-03-31Cons.Profit loss attributable to owners of parent
Net income (owners)−¥2.7bn2022-01-01 → 2022-12-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥40m2022-01-01 → 2022-03-31Cons.Profit loss attributable to owners of parent
Net income−¥168m2023-01-01 → 2023-03-31Cons.Profit loss
Net income¥44m2022-01-01 → 2022-03-31Cons.Profit loss
Total assets¥63.3bnat 2023-03-31Cons.Assets
Total assets¥57.3bnat 2022-12-31Cons.Assets
Total assets¥60.2bnat 2022-03-31Cons.Total assets (5-year summary)
Total liabilities¥40.8bnat 2023-03-31Cons.Liabilities
Total liabilities¥37.9bnat 2022-12-31Cons.Liabilities
Net assets / equity¥22.5bnat 2023-03-31Cons.Net assets
Net assets / equity¥19.4bnat 2022-12-31Cons.Net assets
Net assets / equity¥20.4bnat 2022-03-31Cons.Net assets (5-year summary)
Cash and deposits¥16.8bnat 2023-03-31Cons.Cash and deposits
Cash and deposits¥10.0bnat 2022-12-31Cons.Cash and deposits
EPS (basic)¥-1.462023-01-01 → 2023-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥-23.832022-01-01 → 2022-12-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥0.362022-01-01 → 2022-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (diluted)¥0.362022-01-01 → 2022-03-31Cons.Diluted earnings per share (5-year summary)
Equity ratio35.5%at 2023-03-31Cons.Equity to asset ratio (5-year summary)
Equity ratio33.0%at 2022-12-31Cons.Equity to asset ratio (5-year summary)
Equity ratio33.2%at 2022-03-31Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 26
SegmentItemPeriodValue
Reconciling Itemsreconcilingsegment profit2023-01-01 → 2023-03-31−¥425m
jpcrp040300-q1r_E27054-000Biofuel Businessreportable segmentrevenue2023-01-01 → 2023-03-31¥52m
jpcrp040300-q1r_E27054-000Biofuel Businessreportable segmentrevenue external2023-01-01 → 2023-03-31¥52m
jpcrp040300-q1r_E27054-000Biofuel Businessreportable segmentsegment profit2023-01-01 → 2023-03-31−¥227m
jpcrp040300-q1r_E27054-000Health Care Businessreportable segmentrevenue2023-01-01 → 2023-03-31¥10.0bn
jpcrp040300-q1r_E27054-000Health Care Businessreportable segmentrevenue external2023-01-01 → 2023-03-31¥10.0bn
jpcrp040300-q1r_E27054-000Health Care Businessreportable segmentsegment profit2023-01-01 → 2023-03-31¥572m
jpcrp040300-q1r_E27054-000Others Businessreportable segmentrevenue2023-01-01 → 2023-03-31¥758m
jpcrp040300-q1r_E27054-000Others Businessreportable segmentrevenue external2023-01-01 → 2023-03-31¥758m
jpcrp040300-q1r_E27054-000Others Businessreportable segmentsegment profit2023-01-01 → 2023-03-31−¥95m
Total Of Reportable Segments And Otherssegment totalrevenue2023-01-01 → 2023-03-31¥10.8bn
Total Of Reportable Segments And Otherssegment totalrevenue external2023-01-01 → 2023-03-31¥10.8bn
Total Of Reportable Segments And Otherssegment totalsegment profit2023-01-01 → 2023-03-31¥249m
Reconciling Itemsreconcilingsegment profit2022-01-01 → 2022-03-31−¥370m
jpcrp040300-q1r_E27054-000Biofuel Businessreportable segmentrevenue2022-01-01 → 2022-03-31¥21m
jpcrp040300-q1r_E27054-000Biofuel Businessreportable segmentrevenue external2022-01-01 → 2022-03-31¥21m
jpcrp040300-q1r_E27054-000Biofuel Businessreportable segmentsegment profit2022-01-01 → 2022-03-31−¥178m
jpcrp040300-q1r_E27054-000Health Care Businessreportable segmentrevenue2022-01-01 → 2022-03-31¥10.1bn
jpcrp040300-q1r_E27054-000Health Care Businessreportable segmentrevenue external2022-01-01 → 2022-03-31¥10.1bn
jpcrp040300-q1r_E27054-000Health Care Businessreportable segmentsegment profit2022-01-01 → 2022-03-31−¥129m
jpcrp040300-q1r_E27054-000Others Businessreportable segmentrevenue2022-01-01 → 2022-03-31¥676m
jpcrp040300-q1r_E27054-000Others Businessreportable segmentrevenue external2022-01-01 → 2022-03-31¥676m
jpcrp040300-q1r_E27054-000Others Businessreportable segmentsegment profit2022-01-01 → 2022-03-31−¥48m
Total Of Reportable Segments And Otherssegment totalrevenue2022-01-01 → 2022-03-31¥10.8bn
Total Of Reportable Segments And Otherssegment totalrevenue external2022-01-01 → 2022-03-31¥10.8bn
Total Of Reportable Segments And Otherssegment totalsegment profit2022-01-01 → 2022-03-31−¥356m

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 450
ItemContextValueUnit
Transactions with other segmentsPrior1YTDDuration_ReconcilingItemsMember－JPY
Transactions with other segmentsPrior1YTDDuration－JPY
Net salesPrior1YTDDuration_jpcrp040300-q1r_E27054-000HealthCareBusinessReportableSegmentsMember10124000000JPY
Net salesPrior1YTDDuration_jpcrp040300-q1r_E27054-000BiofuelBusinessReportableSegmentsMember21000000JPY
Net salesPrior1YTDDuration_jpcrp040300-q1r_E27054-000OthersBusinessReportableSegmentsMember676000000JPY
Net salesPrior1YTDDuration_TotalOfReportableSegmentsAndOthersMember10822000000JPY
Net salesPrior1YTDDuration_ReconcilingItemsMember－JPY
Net salesPrior1YTDDuration10822000000JPY
Operating incomePrior1YTDDuration_jpcrp040300-q1r_E27054-000HealthCareBusinessReportableSegmentsMember-129000000JPY
Operating incomePrior1YTDDuration_jpcrp040300-q1r_E27054-000BiofuelBusinessReportableSegmentsMember-178000000JPY
Operating incomePrior1YTDDuration_jpcrp040300-q1r_E27054-000OthersBusinessReportableSegmentsMember-48000000JPY
Operating incomePrior1YTDDuration_TotalOfReportableSegmentsAndOthersMember-356000000JPY
Operating incomePrior1YTDDuration_ReconcilingItemsMember-370000000JPY
Operating incomePrior1YTDDuration-727000000JPY
Direct salesCurrentYTDDuration_jpcrp040300-q1r_E27054-000HealthCareBusinessReportableSegmentsMember8244000000JPY
Direct salesCurrentYTDDuration_jpcrp040300-q1r_E27054-000BiofuelBusinessReportableSegmentsMember－JPY
Direct salesCurrentYTDDuration_jpcrp040300-q1r_E27054-000OthersBusinessReportableSegmentsMember－JPY
Direct salesCurrentYTDDuration_TotalOfReportableSegmentsAndOthersMember8244000000JPY
Direct salesCurrentYTDDuration_ReconcilingItemsMember－JPY
Direct salesCurrentYTDDuration8244000000JPY
DistributionCurrentYTDDuration_jpcrp040300-q1r_E27054-000HealthCareBusinessReportableSegmentsMember890000000JPY
DistributionCurrentYTDDuration_jpcrp040300-q1r_E27054-000BiofuelBusinessReportableSegmentsMember－JPY
DistributionCurrentYTDDuration_jpcrp040300-q1r_E27054-000OthersBusinessReportableSegmentsMember－JPY
DistributionCurrentYTDDuration_TotalOfReportableSegmentsAndOthersMember890000000JPY
DistributionCurrentYTDDuration_ReconcilingItemsMember－JPY
DistributionCurrentYTDDuration890000000JPY
Original equipment manufacturing material overseasCurrentYTDDuration_jpcrp040300-q1r_E27054-000HealthCareBusinessReportableSegmentsMember238000000JPY
Original equipment manufacturing material overseasCurrentYTDDuration_jpcrp040300-q1r_E27054-000BiofuelBusinessReportableSegmentsMember－JPY
Original equipment manufacturing material overseasCurrentYTDDuration_jpcrp040300-q1r_E27054-000OthersBusinessReportableSegmentsMember－JPY
Original equipment manufacturing material overseasCurrentYTDDuration_TotalOfReportableSegmentsAndOthersMember238000000JPY
Original equipment manufacturing material overseasCurrentYTDDuration_ReconcilingItemsMember－JPY
Original equipment manufacturing material overseasCurrentYTDDuration238000000JPY
OthersCurrentYTDDuration_jpcrp040300-q1r_E27054-000HealthCareBusinessReportableSegmentsMember652000000JPY
OthersCurrentYTDDuration_jpcrp040300-q1r_E27054-000BiofuelBusinessReportableSegmentsMember52000000JPY
OthersCurrentYTDDuration_jpcrp040300-q1r_E27054-000OthersBusinessReportableSegmentsMember758000000JPY
OthersCurrentYTDDuration_TotalOfReportableSegmentsAndOthersMember1463000000JPY
OthersCurrentYTDDuration_ReconcilingItemsMember－JPY
OthersCurrentYTDDuration1463000000JPY
Revenue from contracts with customersCurrentYTDDuration_jpcrp040300-q1r_E27054-000HealthCareBusinessReportableSegmentsMember10026000000JPY
Revenue from contracts with customersCurrentYTDDuration_jpcrp040300-q1r_E27054-000BiofuelBusinessReportableSegmentsMember52000000JPY
Revenue from contracts with customersCurrentYTDDuration_jpcrp040300-q1r_E27054-000OthersBusinessReportableSegmentsMember758000000JPY
Revenue from contracts with customersCurrentYTDDuration_TotalOfReportableSegmentsAndOthersMember10837000000JPY
Revenue from contracts with customersCurrentYTDDuration_ReconcilingItemsMember－JPY
Revenue from contracts with customersCurrentYTDDuration10837000000JPY
Revenues from external customersCurrentYTDDuration_jpcrp040300-q1r_E27054-000HealthCareBusinessReportableSegmentsMember10026000000JPY
Revenues from external customersCurrentYTDDuration_jpcrp040300-q1r_E27054-000BiofuelBusinessReportableSegmentsMember52000000JPY
Revenues from external customersCurrentYTDDuration_jpcrp040300-q1r_E27054-000OthersBusinessReportableSegmentsMember758000000JPY
Revenues from external customersCurrentYTDDuration_TotalOfReportableSegmentsAndOthersMember10837000000JPY
Revenues from external customersCurrentYTDDuration_ReconcilingItemsMember－JPY
Revenues from external customersCurrentYTDDuration10837000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identityconsolidated 2022-12-31pass rounding
balance sheet identityconsolidated 2023-03-31pass
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2022-12-31pass
statement vs summary · net assetsconsolidated 2023-03-31pass
statement vs summary · net income attributable to parentconsolidated 2022-01-01/2022-03-31pass
statement vs summary · net income attributable to parentconsolidated 2023-01-01/2023-03-31pass
statement vs summary · revenueconsolidated 2022-01-01/2022-03-31pass
statement vs summary · revenueconsolidated 2023-01-01/2023-03-31pass
statement vs summary · total assetsconsolidated 2022-12-31pass
statement vs summary · total assetsconsolidated 2023-03-31pass